Search
FDA Grants Approval for New Batch of COVID-19 Vaccines with Stringent Criteria
2025-08-28 /
Read about 0 minute
Author：小编
On Wednesday, the U.S. Food and Drug Administration (FDA) authorized a fresh batch of COVID-19 vaccines from Pfizer, Moderna, and Novavax, exclusively designated for individuals aged 65 and older. For individuals younger than 65, the FDA's approval is narrowed to those who possess at least one underlying medical condition and are at heightened risk of severe COVID-19 outcomes. Furthermore, the FDA has rescinded the Emergency Use Authorization for the Pfizer vaccine in children under 5 years old, thereby limiting vaccination options for this particular age group. Similarly, the administration of Moderna and Novavax vaccines is subject to comparable restrictions.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
